Method for preparing high-vitamin C tomato material through gene editing technology
Knocking out the tomato CSN5B gene through CRISPR/Cas9 gene editing technology solves the problem of difficulty in increasing the vitamin C content in tomatoes, and achieves the effect of significantly increasing the vitamin C content, simplifying the breeding process and reducing safety risks.
Patent Information
- Application Number
- CN202411379772.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2024-11-29
AI Technical Summary
The prior art is difficult to effectively increase the vitamin C content in tomatoes. Vitamin C is complex in the body of plants and is affected by the external environment, so it is difficult to increase stably.
By designing sgRNA targets for tomato CSN5B gene, using CRISPR/Cas9 gene editing technology to target CSN5B genes, increasing the vitamin C content in tomatoes, using CRISPR/Cas9 gene editing vector to transform Agrobacterium and infecting the tomato leaves, screening out Homozygous mutant plants of high vitamin C.
Without changing the tomato phenotype, the vitamin C content in the fruit is significantly improved, and the rapid transformation of ordinary varieties into high vitamin C varieties is achieved, simplifying the breeding process and reducing the risk of genetically modified safety.
Smart Images

Figure CN119040328A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of gene engineering technology, and in particular to a method for preparing high-vitamin C tomato materials by gene editing technology. Background Art
[0002] Vitamin C, also known as ascorbic acid (L-ascorbate acid, AsA), is a derivative of hexose. It mainly plays a biological function as an important water-soluble antioxidant molecule and coenzyme factor in plants. Its structure is similar to glucose. It exists in the cells of almost all organisms, including plants, animals, fungi and protozoa. It is an organic acid necessary for aerobic life. In plants, the content of vitamin C is easily affected by the external environment, such as the growth environment, light conditions and soil nutrients. This indispensable nutrient is not only an important antioxidant in plants, but also can maintain plant health and promote plant growth and development. For plants, the presence of vitamin C can help them resist external pressure, maintain the vitality and vitality of plants, and then grow healthily and vigorously. In plants, the synthesis pathways of vitamin C have been analyzed, and it has been found that there are four main synthesis pathways of vitamin C, namely the D-Man / L-Gal pathway, the galacturonic acid pathway, the L-gulose pathway and the inositol pathway. The synthesis of vitamin C is a complex and delicate process. Among these synthesis pathways, the D-Man / L-Gal pathway is unanimously recognized as the most important vitamin C synthesis pathway in plants. The normal operation of this pathway ensures the stable synthesis and supply of vitamin C, providing protection for plant growth, development and health.
[0003] CRISPR / Cas9, as the third-generation gene editing technology, was first discovered in bacteria and archaea. It has been a hot technology in the field of molecular breeding in recent years and has provided new ideas for the rapid creation of tomato materials with high vitamin C content. Summary of the invention
[0004] The purpose of the present invention is to provide a method for preparing high vitamin C tomato materials by gene editing technology to solve the problems existing in the above-mentioned prior art. The present invention designs sgRNA targets for the tomato CSN5B gene and uses CRIPSR / Cas9 gene editing technology to knock out the tomato CSN5B gene in a targeted manner, so that the vitamin C content of tomato fruit is greatly improved without changing the phenotype, providing a new empirical method for breeding tomatoes with high vitamin C content.
[0005] To achieve the above object, the present invention provides the following solutions:
[0006] The present invention provides an sgRNA targeting a tomato CSN5B gene, wherein the sgRNA comprises sgRNA1 and sgRNA2;
[0007] The sequence of the sgRNA1 is the 718th to 793th positions of the sequence shown in SEQ ID NO.8; the sequence of the sgRNA2 is the 1290th to 1365th positions of the sequence shown in SEQ ID NO.8;
[0008] The target sequence of the sgRNA1 is shown as SEQ ID NO.2; the target sequence of the sgRNA2 is shown as SEQ ID NO.3.
[0009] The present invention also provides a CRIPSR / Cas9 gene editing vector for knocking out the tomato CSN5B gene, wherein the CRIPSR / Cas9 gene editing vector comprises the above-mentioned sgRNA.
[0010] Preferably, the nucleotide sequence of the CRIPSR / Cas9 gene editing vector is obtained by connecting the sequence shown in SEQ ID NO.8 and the sequence shown in SEQ ID NO.9.
[0011] The present invention also provides the use of the above-mentioned sgRNA or the above-mentioned CRIPSR / Cas9 gene editing vector in increasing the vitamin C content of tomatoes or breeding high vitamin C tomatoes.
[0012] The present invention also provides a method for preparing a high vitamin C tomato material by gene editing technology, comprising the following steps:
[0013] The CRIPSR / Cas9 gene editing vector is transformed into Agrobacterium, tomato cotyledons are infected using the Agrobacterium transformation method, and homozygous mutant plants are screened to obtain the high vitamin C tomato material.
[0014] Preferably, the method for screening homozygous mutant plants is: extracting genomic DNA of the plant to be tested, performing PCR amplification on the genomic DNA using the primer combination shown in SEQ ID NO.12-13 to obtain a PCR amplification product; sequencing the PCR amplification product, comparing the sequencing result with the wild-type sequence shown in SEQ ID NO.1, and screening homozygous mutant plants according to the comparison result.
[0015] The present invention also provides a method for preparing a non-genetically modified high-vitamin C tomato plant. The high-vitamin C tomato prepared by the above method is self-pollinated, and the self-pollinated progeny with CSN5B gene mutation and no exogenous DNA fragment is screened to obtain the non-genetically modified high-vitamin C tomato plant.
[0016] Preferably, the method for screening the self-pollinated progeny with CSN5B gene mutation and no exogenous DNA fragment is: extracting genomic DNA of the plant to be tested, and performing PCR amplification on the genomic DNA using the primer combination shown in SEQ ID NO.10-11, and the plant to be tested without PCR amplification product is the self-pollinated progeny with CSN5B gene mutation and no exogenous DNA fragment.
[0017] The present invention also provides a CSN5B mutant gene related to the vitamin C content of tomatoes. Compared with the wild-type CSN5B gene, the nucleotide sequence of the CSN5B mutant gene lacks 180 bp between positions 1075-1254. The nucleotide sequence of the wild-type CSN5B gene is shown in SEQ ID NO.1.
[0018] The present invention also provides the use of a reagent for detecting the CSN5B mutant gene in screening high vitamin C tomato varieties.
[0019] The present invention discloses the following technical effects:
[0020] In plants, VTC1 (GDP-mannose pyrophosphorylase) is a key enzyme in the D-Man / L-Gal pathway of vitamin C synthesis, and the activity of the enzyme is negatively regulated by the CSN5B gene. The present invention designs two sgRNA targets based on the tomato CSN5B gene, and thereby designs a CRIPSR / Cas9 gene editing vector targeting the tomato CSN5B gene, and uses the CRIPSR / Cas9 gene editing technology to knock out a specific position of the tomato CSN5B gene, so that the vitamin C content of the tomato fruit is greatly improved without changing the phenotype.
[0021] Experiments have shown that the CSN5B gene can be precisely edited by transforming the CRIPSR / Cas9 gene editing vector into tomato materials to obtain high vitamin C tomato materials, and non-transgenic high vitamin C tomato materials with homozygous mutations in the CSN5B gene can be screened from their self-pollinated progenies. The gene editing method of the present invention is applicable to tomato materials of different varieties, and has high editing efficiency, and can quickly transform ordinary varieties of tomato materials into high vitamin C tomato materials. This method can greatly shorten the breeding time, and is not limited by factors such as linkage drag and transgenic safety, and has great breeding application prospects and economic value. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0023] Figure 1 The structure of the CSN5B gene and the location information of target 1 and target 2, where 1-6 are exons;
[0024] Figure 2 It is a schematic diagram of the structure of the recombinant vector pKSE402-CSN5B;
[0025] Figure 3 is the PCR amplification result of CSN5B gene of T0 generation plants; wherein, M is a marker, - is a negative blank control, WT is an untransformed wild-type plant, and 1-29 is a T0 generation tomato plant;
[0026] Figure 4 This is the sequencing result of CSN5B gene in T0 generation plants;
[0027] Figure 5 The results of the determination of vitamin C content in the fruits of the T0 generation homozygous csn5b-6 and the wild type;
[0028] Figure 6 The results of PCR detection of exogenous T-DNA and CSN5B gene in the self-pollinated progeny (T1 generation) of the homozygous deletion csn5b-6; A is the PCR detection result of exogenous T-DNA insertion in the T1 generation plant after self-pollination of csn5b-6, and B is the PCR detection result of CSN5B gene in the T1 generation plant after self-pollination of csn5b-6; M is a marker, - is a negative blank control, WT is the self-pollinated progeny of the wild-type plant, and 1-15 is the self-pollinated progeny of the homozygous deletion csn5b-6;
[0029] Figure 7 The fruit phenotypes of the self-pollinated progeny (T1 generation) of the homozygous csn5b-6 without exogenous T-DNA insertion and the wild type;
[0030] Figure 8 These are the results of the determination of vitamin C content in the fruits of the self-pollinated progeny (T1 generation) of the deletion homozygous csn5b-6 without exogenous T-DNA insertion and the wild-type plants. DETAILED DESCRIPTION
[0031] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0032] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0033] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0034] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.
[0035] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0036] The quantitative tests in the following embodiments of the present invention were all repeated three times, and the results were averaged.
[0037] The wild-type tomato material used in the following examples of the present invention is the tomato yellow leaf curl virus-resistant tomato variety 'Ty205' bred in the Plant Genetic Engineering Laboratory of Hebei University of Science and Technology.
[0038] The pKSE402 vector in the following embodiments of the present invention is a vector modified by the Plant Genetic Engineering Laboratory of Hebei University of Science and Technology from the pHSE401 vector in the document "HL, Dong, L., Wang, ZP, Zhang, HY, Han, CY, Liu, B., & Chen, QJ (2014). A CRISPR / Cas9 toolkit for multiplex genome editing in plants. BMC plant biology, 14, 1-12." The specific modification method is to replace the hygromycin resistance gene (HYG) on the T-DNA in the pHSE401 vector with the kanamycin resistance gene (NPTII), that is, the vector pKSE402. The public can obtain it from the applicant, and the biological material is only used for repeating the relevant experiments of the present invention and cannot be used for other purposes.
[0039] The 2×Rapid Taq Master Mix polymerase used in the following examples of the present invention is a product of Nanjing Vazyme Biotechnology Co., Ltd., T4 DNA ligase and restriction endonuclease are products of Sanshi Biotechnology Co., Ltd.; the PCR product purification kit is a product of Omega; the primers are synthesized by Shanghai Bioengineering Co., Ltd.; the sequencing is completed by Beijing Qingke Sequencing Co., Ltd.; and the remaining reagents are analytical grade reagents.
[0040] Example 1 Construction of CRIPSR / Cas9 gene editing vector pKSE402-CSN5B
[0041] 1. Obtaining the sgRNA target sequence of the CSN5B gene
[0042] The CSN5B gene sequence (SEQ ID NO.1, GenBank ID CU302231.4, gene number Solyc11g017300.1) was queried according to the SGN database (http: / / solgenomics.net / ):
[0043]
[0044] The structure of the gene was analyzed and the results were as follows Figure 1 As shown in Figure 1, the CSN5B gene has 6 exons (labeled 1-6). The CDS sequence of the gene was input into the CRISPR target design website (http: / / crispor.tefor.net / ). Two targets (19 bp in length, followed by PAM) were selected in the first exon region based on the specificity score and target editing efficiency score. The PAM sequence was set to NGG, and the species data was set to Tomato (Solanum lycopersicum) str. Heinz 1706 genome SL2.50. The sgRNA targets finally selected are as follows: Figure 1 The specific sequence is as follows:
[0045] CSN5B gene sgRNA target 1: 5'-GCACCGGAAAACTCTGCGT-3' (SEQ ID NO. 2);
[0046] CSN5B gene sgRNA target 2: 5'-GGAGGTACAATTGAGGTAA-3' (SEQ ID NO. 3).
[0047] 2. Construction of CRIPSR / Cas9 gene editing vector for CSN5B gene
[0048] 2.1 Design of sgRNA amplification primers
[0049] According to the selected target sequence, sgRNA amplification primers were designed and constructed. The design method was to replace the first 19bp target sequence with the 19bp N in DT1-BsF and DT1-F0, and the inverted complementary sequence of the other 19bp target sequence with the 19bp N in DT2-R0 and DT2-BsR. The specific primer sequences of DT1-BsF, DT1-F0, DT2-R0 and DT2-BsR are as follows:
[0050] DT1-BsF: 5'-ATATATGGTCTCGATTG GCACCGGAAAACTCTGCGT GTT-3' (SEQ ID NO. 4);
[0051] DT1-F0:5'-TG GCACCGGAAAACTCTGCGT GTTTTAGAGCTAGAAATAGC-3' (SEQ ID NO.5);
[0052] DT2-R0:5'-AAC GGAGGTACAATTGAGGTAA CAATCTCTTAGTCGACTCTAC-3'(SEQ IDNO.6);
[0053] DT2-BsR: 5'-ATTATTGGTCTCTAAAC GGAGGTACAATTGAGGTAA CAA-3' (SEQ ID NO. 7).
[0054] Among them, the underlined sequence in primers DT1-BsF and DT1-F0 is target 1, the underlined sequence in primers DT2-R0 and DT2-BsR is target 2 sequence, and the bold position is the restriction site.
[0055] 2.2 Construction of CRIPSR / Cas9 gene editing vector pKSE402-CSN5B
[0056] (1) Construction of recombinant plasmid pKSE402-CSN5B
[0057] Using plasmid pCBC-DT1DT2 as a template and DT1-BsF, DT1-F0, DT2-R0 and DT2-BsR as primers, PCR amplification was performed to obtain a PCR amplification product and a target sgRNA nucleotide fragment with restriction sites on both sides. The PCR reaction conditions are as follows:
[0058] The PCR reaction system was: 2× Rapid Taq Master Mix 10 μL, primers DT1-F0 and DT2-R0 0.5 μL each, primers DT1-BsF and DT2-BsR 1 μL each, plasmid template 20 ng, double distilled water to 20 μL. The PCR reaction program was: denaturation at 98°C for 10 seconds, annealing at 66°C for 5 seconds, extension at 72°C for 5 seconds, for a total of 30 cycles.
[0059] After the PCR amplification product was purified, it was digested with BsaI and then ligated with the pKSE402 vector that had been digested with the same enzyme using a DNA ligation kit to obtain the recombinant plasmid pKSE402-CSN5B, which was then sequenced. The sequencing results showed that the nucleotide sequence of the recombinant plasmid pKSE402-CSN5B was 17762 bp in length and consisted of the first half (SEQ ID NO.8) and the second half (SEQ ID NO.9) connected end to end. The structure of the recombinant plasmid pKSE402-CSN5B is shown in the figure below. Figure 2As shown. It includes the LB recognition sequence of the T-DNA region (positions 2504-2528 of SEQ ID NO.9), the NOS promoter for initiating the expression of the resistance screening gene NPTII, the resistance screening gene NPTII (positions 1398-2195 of SEQ ID NO.9), the OCS terminator for terminating the expression of the resistance screening gene NPTII, the 35S promoter for initiating the expression of the coding gene of the Cas9 protein, the coding gene of the Cas9 protein (positions 2593-6693 of SEQ ID NO.8), the NOS terminator for terminating the expression of the coding gene of the Cas9 protein, the U6 promoter (U6-26p) for initiating the expression of the coding gene of sgRNA1, the coding gene of sgRNA1, the U6 promoter (U6-29p) for initiating the expression of the coding gene of sgRNA2, the coding gene of sgRNA2, and the RB recognition sequence of the T-DNA region (positions 21-45 of SEQ ID NO.8). Among them, the coding gene of sgRNA1 is shown in the 718-793th position of SEQ ID NO.8, and the target sequence of sgRNA1 is shown in the 699-717th position of SEQ ID NO.8; the coding gene of sgRNA2 is shown in the 1290-1365th position of SEQ ID NO.8, and the target sequence of sgRNA2 is shown in the 1271-1289th position of SEQ ID NO.8. The above results show that the gene editing vector pKSE402-CSN5B was successfully constructed.
[0060] SEQ ID NO.8:
[0061]
[0062] SEQ ID NO.9:
[0063]
[0064] Example 2 Preparation of high vitamin C tomato material by gene editing technology
[0065] 1. Transform the gene editing vector pKSE402-CSN5B into Agrobacterium
[0066] Take 1 μg of the gene editing vector pKSE402-CSN5B prepared in Example 1 and place it in 100 μL of GV3101 competent cells, cool it in liquid nitrogen for 5 minutes, place it in a 37°C water bath, and heat shock it for 5 minutes. Take it out of the water bath and place it on ice for 5 minutes, and add 800 μL of LB liquid culture medium without resistance to the clean bench. Activate the bacteria on a shaker at 28°C 100rpm for 2h. Centrifuge at 28°C 6000rpm for 5min. Discard 750 μL of the supernatant, blow and beat the remaining bacterial solution evenly, resuspend it and evenly apply it to LB solid culture medium containing 50 mg / L kanamycin and 25 mg / L rifampicin resistance, and culture it in the dark at 28°C for 2d. The primers (Cas9-F / Cas9-R) designed with the nucleotide sequence encoding Cas9 were used to perform conventional PCR detection on single colonies, and the band size of 600 bp was determined as a positive recombinant bacterium, and the recombinant bacterium was named pKSE402-CSN5B / GV3101. After shaking culture of the positive recombinant bacteria, 50% glycerol was added and mixed, and then frozen at -80°C for later use.
[0067] The primer sequences used for bacterial liquid PCR identification are as follows:
[0068] Cas9-F: gagaagcaggcccatttatatgg (SEQ ID NO.10);
[0069] Cas9-R: agccctcttctttcgatccatcaac (SEQ ID NO. 11).
[0070] 2. Obtaining and identifying T0 generation CSN5B gene-edited plants
[0071] 2.1 Obtaining T0 generation regenerated plants
[0072] Agrobacterium GV3101 containing the target vector was used to infect the cotyledons that were cultured in the dark for 1 day. After the infection ended for 15 minutes, the bacterial solution was poured out, and the bacterial solution on the cotyledons was dried with sterile filter paper, and the cotyledons were inoculated in a KCMS medium with a pH of 5.8 containing sterile filter paper, with the back facing up, and cultured in the dark at 26°C in an incubator for 2 days. The cultured explants were moved to a 2Z differentiation medium containing 2 mg / L zeatin, 200 mg / L timentin, 75 mg / L kanamycin, and a pH of 5.8. After about 4 weeks of culture, adventitious buds were differentiated. When the adventitious buds grew to about 3 cm, they were cut off and transferred to a rooting medium containing 3 mg / L IBA, 100 mg / L timentin, and a pH of 5.8 for rooting to obtain plants, which were T0 generation regenerated plants.
[0073] 2.2 Obtaining T0 generation CSN5B gene-edited plants
[0074] The genomic DNA of the T0 generation regenerated plants was extracted by CTAB method, and the exogenous DNA fragments were amplified by PCR using genomic DNA as template and Cas9-F and Cas9-R as primers. The PCR reaction system was: 2×RapidTaqMaster Mix 5μL, 0.5μL of each of the front and back primers, 1μL of genomic DNA, and double distilled water to 10μL; the PCR reaction conditions were: 98℃ denaturation for 10 seconds, 59℃ annealing for 5 seconds, 72℃ extension for 5 seconds, for a total of 30 cycles.
[0075] After testing, the results are as follows Figure 3 As shown, it can be seen that 17 out of 29 T0 generation regenerated plants had exogenous DNA inserted.
[0076] The genomic DNA of the regenerated plants with exogenous DNA inserted in the T0 generation was used as a template, and the CSN5B gene was amplified by PCR using CSN5B-F and CSN5B-R as primers. The PCR amplification products were sent for testing. The PCR reaction system was: 2×Rapid Taq Master Mix 10μL, 1μL of each of the front and back primers, 2μL of genomic DNA, and double distilled water to 20μL; the PCR reaction conditions were: 98℃ denaturation for 10 seconds, 59℃ annealing for 5 seconds, 72℃ extension for 5 seconds, for a total of 30 cycles.
[0077] Among them, CSN5B-F: cgtaagcacgctgaagatctca (SEQ ID NO. 12);
[0078] CSN5B-R: cgcatcagcttgagcattaaccc (SEQ ID NO. 13).
[0079] The sequencing results of PCR products are as follows Figure 4As shown. Among the 17 T0 generation regenerated plants, a total of 6 plants were mutated, of which 2 were homozygous mutants (CSN5B genes of two homologous chromosomes of the plant had the same mutation), named csn5b-6 and csn5b-8, and 4 were heterozygous mutants, with an editing efficiency (number of plants with edited CSN5B genes / total number of regenerated plants) of 35.3%. Among them, the CSN5B gene sequence of the csn5b-6 homozygous mutant plant was formed by deleting 180bp sequence between the 1075-1254th position of the CSN5B gene (SEQ ID NO.1) of the two homologous chromosomes of the wild-type tomato.
[0080] The vitamin C / ascorbic acid (AsA) assay kit of Nanjing Jiancheng Biotechnology Co., Ltd. was used to determine the total vitamin C content of the T0 generation homozygous mutant plant csn5b-6. The results showed that the vitamin C content of the fruit of the CSN5B gene deletion homozygous mutant csn5b-6 was significantly increased compared with the wild type, which was 1.38 times that of the wild type (WT) ( Figure 5 ).
[0081] Example 3 Acquisition and identification of non-transgenic high vitamin C tomato materials
[0082] 1. Detection of exogenous DNA fragments
[0083] The CSN5B gene deletion homozygous mutant csn5b-6 plant was self-pollinated to obtain T1 generation seeds; 25 T1 generation seeds were sown, and after true leaves grew, T1 generation plants of CSN5B gene deletion homozygous mutant csn5b-6 were obtained. The genomic DNA of the T1 generation single plant of the homozygous mutant csn5b-6 was used as a template, and Cas9-F and Cas9-R were used as primers to perform PCR amplification and electrophoresis on the exogenous T-DNA fragment. Plants without PCR amplification products were selected, which were the progeny plants of csn5b-6 that did not carry exogenous T-DNA insertion.
[0084] After testing ( Figure 6 A), 4 out of 15 strains in the T1 generation of self-pollinated csn5b-6 did not carry the exogenous T-DNA fragment.
[0085] 2. Detection of CSN5B gene mutation sequence
[0086] Using the genomic DNA of csn5b-6 progeny plants without exogenous T-DNA fragments as template, CSN5B-F and CSN5B-R were used to amplify the CSN5B gene fragment by PCR and electrophoresis analysis.
[0087] After testing ( Figure 6B), the size of the CSN5B gene amplification product of the wild-type plant is 756bp, while the size of the CSN5B gene amplification product of the T1 generation (No. 1-15) obtained by self-pollination of the homozygous mutant csn5b-6 plant is 576bp, which is 180bp less than that of the wild type, indicating that the self-pollinated progeny of the homozygous mutant csn5b-6 plant are all homozygous deletion mutant plants of the CSN5B gene.
[0088] Phenotypic observations of the T1 generation plants without exogenous T-DNA insertion and deletion homozygous csn5b-6 showed no significant differences in plant growth compared to the wild type (WT), and no significant changes in the shape and color of mature fruits ( Figure 7 ).
[0089] The vitamin C / ascorbic acid (AsA) assay kit of Nanjing Jiancheng Biotechnology Co., Ltd. was used to determine the total vitamin C content of the T1 generation. The results showed that the vitamin C content of the fruits of the deletion homozygotes csn5b-6-1 and csn5b-6-7 without exogenous T-DNA insertion in the T1 generation was significantly increased compared with the wild type (WT), which was 1.39 times and 1.37 times that of the wild type, respectively ( Figure 8 ).
[0090] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims
1. A sgRNA targeting tomato CSN5B gene, characterized in that: The sgRNA includes sgRNA1 and sgRNA2; The sequence of the sgRNA1 is the 718th to 793th position of the sequence shown in SEQ ID NO.8; the sequence of the sgRNA2 is the 1290th to 1365th position of the sequence shown in SEQ ID NO.8; The target sequence of the sgRNA1 is shown in SEQ ID NO.2; the target sequence of the sgRNA2 is shown in SEQ ID NO.
3.
2. A CRIPSR / Cas9 gene editing vector for knocking out the tomato CSN5B gene, characterized in that: The CRIPSR / Cas9 gene editing vector comprises the sgRNA described in claim 1.
3. The CRIPSR / Cas9 gene editing vector according to claim 2, characterized in that: The nucleotide sequence of the CRIPSR / Cas9 gene editing vector is obtained by connecting the sequence shown in SEQ ID NO.8 and the sequence shown in SEQ ID NO.
9.
4. Use of the sgRNA according to claim 1 or the CRIPSR / Cas9 gene editing vector according to claim 2 or 3 in increasing the vitamin C content of tomatoes or breeding high vitamin C tomatoes.
5. A method for preparing high vitamin C tomato material by gene editing technology, characterized in that: The steps include: The CRIPSR / Cas9 gene editing vector described in claim 2 or 3 is transformed into Agrobacterium, tomato cotyledons are infected by the Agrobacterium transformation method, and homozygous mutant plants are screened to obtain the high vitamin C tomato material.
6. The method according to claim 5, characterized in that The method for screening homozygous mutant plants is as follows: extracting genomic DNA from the plant to be tested, performing PCR amplification on the genomic DNA using the primer combination shown in SEQ ID NO.12-13 to obtain a PCR amplification product; sequencing the PCR amplification product, comparing the sequencing result with the wild-type sequence shown in SEQ ID NO.1, and screening homozygous mutant plants according to the comparison result.
7. A method for preparing non-genetically modified high vitamin C tomato plants, characterized in that: The high vitamin C tomato prepared by the method of claim 5 or 6 is self-pollinated, and the self-pollinated progeny with CSN5B gene mutation and no exogenous DNA fragment is screened to obtain the non-transgenic high vitamin C tomato plant.
8. The preparation method according to claim 7, characterized in that: The screening method for the self-pollinated progeny with CSN5B gene mutation and no exogenous DNA fragment is as follows: extracting genomic DNA of the plant to be tested, and performing PCR amplification on the genomic DNA using the primer combination shown in SEQ ID NO.10-11. The plant to be tested without PCR amplification product is the self-pollinated progeny with CSN5B gene mutation and no exogenous DNA fragment.
9. A CSN5B mutant gene related to vitamin C content in tomatoes, characterized in that: Compared with the wild-type CSN5B gene, the nucleotide sequence of the CSN5B mutant gene lacks 180 bp between positions 1075-1254; the nucleotide sequence of the wild-type CSN5B gene is shown in SEQ ID NO.
1.
10. Use of a reagent for detecting the CSN5B mutant gene according to claim 9 in screening high vitamin C tomato varieties.
Citation Information
Cited By
Method for constructing pepper plant mutant through visual marker gene editing
CN120485243A
